Advertisement

Topics

FDA approves Alnylam’s siRNA drug Onpattro for rare disorder

14:00 EDT 12 Aug 2018 | MedCity News

Red seal and imprint "FDA APPROVED" on white surface. FDA - Food and Drug Administration is a federal agency of the United States Department of Health and Human Services.

The drug is the first approved treatment for the condition, as well as the first siRNA drug to win the agency’s approval.

Original Article: FDA approves Alnylam’s siRNA drug Onpattro for rare disorder

NEXT ARTICLE

More From BioPortfolio on "FDA approves Alnylam’s siRNA drug Onpattro for rare disorder"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...